NCT06200025

Brief Summary

Virtual reality-based aphasia rehabilitation has been shown to improve the language skills of individuals with aphasia in the chronic period after stroke. However, non-immersive or semi-immersive rehabilitation methods have often been adopted in the studies. Considering the importance of the visual given to the patient for naming, it can be thought that full immersive therapy may be more effective. Therefore, the aim of this study was to investigate the effect of cue-based aphasia naming therapy in a fully immersive virtual reality environment on aphasia severity and aphasia-related quality of life and to compare it with standard cue treatments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 29, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 10, 2024

Completed
Last Updated

January 10, 2024

Status Verified

December 1, 2023

Enrollment Period

1.7 years

First QC Date

December 29, 2023

Last Update Submit

December 29, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Gülhane Aphasia Test

    Gülhane Aphasia Test-2 (GAT-2) was used to assess aphasia severity. GAT-2 is a valid and reliable test developed by Maviş et al. to evaluate aphasia and to obtain information about motor speech disorders such as dysarthria and apraxia that may accompany aphasia. The GAT-2 consists of 7 subsections: speech fluency, listening comprehension, reading comprehension, oral-motor evaluation, automatic speech, repetition and naming. A maximum total score of 82 can be obtained and higher scores are associated with better speech function.

    through study completion, an average of 1 year

Secondary Outcomes (1)

  • Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39)

    through study completion, an average of 1 year

Study Arms (2)

Virtual Reality Group

EXPERIMENTAL

visual and auditory cue-based aphasia rehabilitation program in full immersive virtual reality

Other: Cue-based speech therapy in virtual reality

Conventional Group

ACTIVE COMPARATOR

visual and auditory cue-based aphasia rehabilitation program

Other: Cue-based speech therapy

Interventions

Treatment applied with virtual reality headsets to provide 3d visual and auditory cues to individuals in a virtual environment. A treatment environment where the provision of cues can be controlled by the therapist, interacting with 3d clues and receiving feedback on the accuracy of the named objects.

Virtual Reality Group

Treatment involving the assessment of language skills and the presentation of communication strategies to the individual, including the use of personalized phonological cues.

Conventional Group

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with non-fluent aphasia by a neurologist
  • at least 4 months after stroke
  • A score of 29 and above on the language score sub-item of the GAT scale

You may not qualify if:

  • severe sensory impairments (vision, hearing) that prevent participation in therapies
  • severe motor dysfunction
  • apraxia
  • neglect
  • dementia
  • psychiatric disorders
  • D vision problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Health Sciences Bolu Abant Izzet Baysal University

Bolu, Merkez, 14100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Ischemic StrokeAphasia

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesSpeech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ramazan Kurul, Ph.D

    Abant Izzet Baysal University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: two groups with a conventional control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 29, 2023

First Posted

January 10, 2024

Study Start

October 15, 2021

Primary Completion

July 1, 2023

Study Completion

September 15, 2023

Last Updated

January 10, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations